Veriti Management LLC Biogen Inc. Transaction History

Veriti Management LLC

$1.33 Billion
Q1 2024

A detailed history of Veriti Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Veriti Management LLC holds 1,740 shares of BIIB stock, worth $393,936. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,740

Previous 1,841 5.49%

Holding current value

$393,936

Previous $476,000 21.22%

% of portfolio

0.03%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$212.02 - $267.71 $21,414 - $27,038	-101 Reduced 5.49%	1,740 $375,000
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $37,172 - $44,745	167 Added 9.98%	1,841 $476,000
Q3 2023 Oct 27, 2023	SELL	$253.3 - $285.89 $63,325 - $71,472	-250 Reduced 12.99%	1,674 $430,000
Q2 2023 Jul 13, 2023	BUY	$275.25 - $318.06 $40,186 - $46,436	146 Added 8.21%	1,924 $548,000
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $4,618 - $5,262	18 Added 1.02%	1,778 $494,000

Q4 2022 Jan 20, 2023	BUY	$252.44 - $306.72 $97,946 - $119,007	388 Added 28.28%	1,760 $0
Q3 2022 Oct 26, 2022	BUY	$194.69 - $268.46 $22,194 - $30,604	114 Added 9.06%	1,372 $366,000
Q2 2022 Jul 18, 2022	BUY	$187.54 - $223.02 $5,813 - $6,913	31 Added 2.53%	1,258 $257,000
Q1 2022 Apr 11, 2022	BUY	$193.77 - $244.14 $19,377 - $24,414	100 Added 8.87%	1,227 $258,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $26,646 - $34,244	-119 Reduced 9.55%	1,127 $270,000
Q3 2021 Oct 08, 2021	BUY	$282.99 - $369.05 $56,598 - $73,810	200 Added 19.12%	1,246 $353,000
Q2 2021 Jul 13, 2021	SELL	$259.0 - $414.71 $120,176 - $192,425	-464 Reduced 30.73%	1,046 $362,000
Q1 2021 Apr 14, 2021	BUY	$242.95 - $284.63 $30,611 - $35,863	126 Added 9.1%	1,510 $422,000
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $326,983 - $492,191	1,384 New	1,384 $339,000

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.

Account

Veriti Management LLC Biogen Inc. Transaction History